Propionyl-L-carnitine for intermittent claudication
Editorial Group: Cochrane Peripheral Vascular Diseases Group
Published Online: 12 SEP 2012
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
de Backer TLM, Campens L, Vander Stichele R, Van Bortel L, De Bacquer D. Propionyl-L-carnitine for intermittent claudication (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 9. Art. No.: CD010117. DOI: 10.1002/14651858.CD010117.
- Publication Status: New
- Published Online: 12 SEP 2012
This is the protocol for a review and there is no abstract. The objectives are as follows:
The objective of this review is to determine whether propionyl-L-carnitine is efficacious compared with placebo, other active drugs or with any other intervention for intermittent claudication (exercise, angioplasty, surgery) in increasing pain-free and maximum walking distance for patients with stable intermittent claudication, Fontaine stage II.